Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ

Fig. 1

a–d There was no significant difference between untreated DM mice (control group) and imeglimin-treated DM mice (imeglimin group) in non-fasting and fasting blood glucose levels and body weights. e–h Total cholesterol, triglyceride, HDL-cholesterol and LDL-cholesterol levels were not significantly different between the two groups. Black squares and bars, untreated DM mice (control group); White squares and bars, imeglimin-treated DM mice (imeglimin group). n = 9–12

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840